Angiogenesis, the process by which new blood vessels grow from existing vasculature, is normally involved in tissue growth, development and wound healing. Tumors require neovascularization for growth so angiogenesis has become an important pathway for cancer diagnosis and treatment. Angiogenesis is also important for the study and treatment of diabetes mellitus, macular degeneration, and cardiovascular disease.
Measuring the levels of angiogenesis-related proteins may provide prognostic information concerning disease processes and could also be used to monitor therapeutic efficacy during clinical development.
Myriad RBM’s AngiogenesisMAP® quantifies nearly 60 proteins involved in angiogenesis to help researchers better understand disease mechanisms and therapeutic interventions.
1 This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only.
2 This assay did not meet performance specifications in Serum and results should be used for information purposes only.
Intended for Research Use Only.
|Serum or plasma||Other fluids*|
|140 µL||500 µL|